Xencor | 资产



Assets 更改 日
AbbVie USD 135.16B 8.26B 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amgen USD 91.84B 956M 2024-12
Arrowhead Research USD 1.01B 126.11M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
J&J USD 180.1B 1.82B 2024-12
MacroGenics USD 264.49M 63.36M 2024-09
Merck USD 117.11B 426M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Xencor USD 951.94M 31.69M 2024-12



Xencor 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2025.